Unicoat Pharma ApS: Financial statements 2017
CVR: 37166707
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Unicoat Pharma ApS (CVR 37166707) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 431,044 and a net result of DKK 343,853. Equity in the 2017 report amounted to DKK 427,700. The solvency ratio was 27.9%.
- Gross Profit
- DKK 431,044
- Profit/Loss
- DKK 343,853
- Equity
- DKK 427,700
- Total Assets
- DKK 1,533,794
Official annual report
Keep an eye on Unicoat Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Unicoat Pharma ApS has published its interim report for the period October 20, 2015 – December 31, 2016.
About Unicoat Pharma ApS
Unicoat Pharma ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2015. The company is registered under the industry Overfladebehandling af metal. The management consists of Morten Clausen, Amanda Ryberg and Magnus Knorr Clausen. The company is owned by M C Holding ApS, MCVA Holding ApS and A Ryberg Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 867,952 and a net result of DKK 680,181 compared with DKK 638,057 the year before. Equity in the 2025 report amounted to DKK 507,241.